Digital chemical manufacturing platform DigiChem Corporation has signed a least at 500 White Plains Rd. in Tarrytown, the only turnkey lab facility available in the Westchester market.
DigiChem is the latest startup to emerge from BioInc@NYMC, the biotechnology incubator on the Valhalla campus of New York Medical College. The company signed a five-year lease for 3,035 square feet of lab space on the fifth floor of 500 White Plains Rd., a 155,987-square-foot Class A office and laboratory building owned by Northpath Investments.
This is the second BioInc@NYMC startup to open its first permanent location at 500 White Plains Rd. Sapience Therapeutics, a clinical-stage biotechnology company, leased 8,352 square feet of second floor lab space at the property in 2022.
Northpath Investments acquired 500 and 540 White Plains Rd. in 2020 and leased the majority of the research and development facility at building 500 back to the seller, chemical giant BASF Corporation.
“We are thrilled to welcome DigiChem to our roster of leading tenants,” said Gershon Alexander, of Northpath Investments. “500 White Plains Rd. is uniquely positioned to accommodate the region’s growing life science sector with state-of-the-art, turnkey lab space in an ideal location.”
A JLL team led by Executive Vice President Ian Ceppos and Senior Vice President John Cahill serves as the exclusive leasing agent for the available space across the entire 155,000-square-foot, hub located within the Tarrytown Corporate Center in Westchester County. DigiChem was represented by Michael Litsky of Rakow Commercial Realty Group.
“Westchester’s life science incubators are playing a critical role in the development of new medical therapies and devices and in the creation of dynamic new companies,” Ceppos said. “500 White Plains Rd. provides superior, cost-efficient lab and office space to support the business goals of young companies.”
